Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Negative control for VH 298
which inhibiting apoptosis in bupivacaine-challenged SH-SY5Y cells is overturned by LY294002 treatment and counteracts bupivacaine-induced injury via activating the PI3K/PKB pathway
Chemical Name: 4-((3-(4-(4-((2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-3-oxo-2
Smiles: O=C1C2C=CC=C(NC(=O)COCCOCCOCCOCCOCCOCCCCCCI)C=2C(=O)N1C1CCC(=O)NC1=O
Pramipexole dihydrochloride hydrate attenuates levodopa-induced toxicity in mesencephalic cultures
Ginsenoside Rh3 - CAS# 105558-26-7 0 Racemate Negative control for VH 298Ginsenoside Rh3 is a bacterial metabolite of Ginsenoside Rg5. Ginsenoside Rh3 treatment in human retinal cells induces Nrf2 activation. Product information CAS Number: 105558 26 7 Molecular Weight: 604. 86 Formula: C36H60O7 Chemical Name: (2R,3R,4S,5S,6R) 2 {[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR) 11 hydroxy 3a,3b,6,6,9a pentamethyl 1 [(2Z) 6 methylhepta 2,5 dien 2 yl] hexadecahydro 1H cyclopenta[a]phenanthren 7 yl]oxy} 6 (hydroxymethyl)oxane 3,4,5
US$ 42.00
US$ 42.00
US$ 47.00
US$ 335.07
US$ 57.00
US$ 55.00
US$ 30.00
US$ 156.94
US$ 314.61
US$ 36.00
US$ 47.00
US$ 25.00
US$ 81.00
US$ 47.00
US$ 244.21